Urological problems involving lower urinary tract symptoms (LUTS) such as urinary frequency, urgency, nocturia, and urine volume have a significant impact on patient health and quality of life. At present, clinical uroflowmeter tests and a urination frequency-volume chart (FVC) or bladder diary is recommended for monitoring the symptoms and the efficacy of treatment. However, these solutions are intermittent, needing high user compliance, repeated visits to the clinic and are inconvenient, especially for elderly patients. Such limitations lead to misdiagnosis and an inability to personalise treatments. This work proposes i-Flow, a low-power bio-impedance sensing system enabling wearable uroflowmetry. To demonstrate the effectiveness of the proposed solution, a preliminary dataset has been collected from 6 healthy subjects. Furthermore, the dataset acquired with a developed wearable system has been used to design a low-complexity, lightweight bladder voiding measurement algorithm and evaluates the overall hardware-software performance. In addition, repeatability tests on a single subject with multiple voiding instances (n=5) were conducted. The experimental evaluation demonstrates high-performance bladder voiding estimation with the total end volume (TEV) error for multi-subject voiding instances to be 38.4±18 ml. While the TEV error for repeated measures with a single subject was 21.7±15 ml for five voiding instances. The presented system for recording bladder voiding achieves an unobtrusive, comfortable and reliable method for automated recording of the frequency of voiding, the total voided volume and urine flowrate. Thus providing a means of conducting uroflowmetry tests in at-home settings while also maintaining a digital bladder diary devoid of human lapses. Such a system has the ultimate goal of assisting in diagnosis and personalizing treatment of LUTS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1109/EMBC53108.2024.10782558 | DOI Listing |
Urology
March 2025
Faculty of Medicine and Health Sciences, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium; Department of Urology, Antwerp University Hospital, Drie Eikenstraat 655, 2650 Edegem, Belgium; Antwerp Surgical Training, Anatomy and Research Centre (ASTARC), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium. Electronic address:
Objectives: To analyse individual VV-Qmax plots based on multiple home uroflowmetries and compare these with cross-sectional nomograms.
Methods: Healthy volunteers (16-69 years) without LUTS were asked to take a Minze Homeflow device home to register 25 uroflows. Participants reporting urinary tract disorders, malignancy or medication affecting bladder function were excluded.
Neurogenic bladder (NB) is a group of bladder and/or urethral dysfunctions caused by neurological lesions, commonly seen in patients with lumbar spine diseases, manifesting as urinary storage and voiding dysfunction, significantly affecting patients' quality of life. Degenerative changes or trauma to the lumbar spine can lead to narrowing of the dural sac, compressing the sacral nerve roots, cauda equina or blood vessels, causing bladder dysfunction and leading to NB. Diagnostic methods for NB include history taking, physical examination and noninvasive and invasive tests, such as urodynamic testing and cystoscopy.
View Article and Find Full Text PDFBJU Int
March 2025
Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada.
Background: Exercise-induced urinary incontinence (UI) can hinder physical activity, particularly in women engaging in high-impact activities. This condition is linked to reduced passive support of the urethra and bladder. Intravaginal devices that support pelvic structures may offer a solution, but high-quality evidence is lacking.
View Article and Find Full Text PDFFront Neurol
February 2025
Department of Urology, Hangzhou Third People's Hospital, Hangzhou, China.
Objective: The objective of this study was to investigate the effectiveness and safety of sacral magnetic stimulation (SMS) in the management of detrusor underactivity (DU).
Methods: We retrospectively analyzed 66 patients with detrusor underactivity treated at Hangzhou Third People's Hospital from January 2020 to October 2024, divided into two groups (33 cases each). Both groups had confirmed detrusor underactivity via urodynamic studies.
Mol Med
March 2025
School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, No. 232, Waihuan East Road, Guangzhou Higher Education Mega Center, Panyu District, Guangzhou, 510006, Guangdong, China.
Background: Diabetic cystopathy (DCP) is linked to bladder nerve conduction disorders, with diabetes-induced neuropathy impairing nerve signal transmission and causing bladder dysfunction. Myosin 5a, vital for neuronal transport, has been linked to neurological disorders, though its role in DCP remains unclear. The objective of this study was to investigate whether Myosin 5a plays a potential regulatory role in Diabetic Cystopathy.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!